RAVEL Trial; Remifentanil patient-controlled analgesia (RPCA) vs epidural analgesia (EA) during labour

RAVEL Trial; Remifentanil patient-controlled analgesia (RPCA) vs epidural analgesia (EA) during labour - RAVEL Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38234

Enrollment

1136

Registered

2010-12-23

Start date

2011-05-30

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain during labour

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >18 years Labour between 32-42 weeks of gestation ASA physical status I or II

Exclusion criteria

Exclusion criteria: Prior administration of regional of opioid analgesia Drug allergy: history of hypersensitivity to opioid or local anesthetic substances Initial maternal SpO2 of less than 95% Initial maternal temperature of 38C or higher. Contra-indication for epidural analgesia

Design outcomes

Secondary

Measure	Time frame
Maternal and Neonatal Side effects of both strategies.	—

Primary

Measure	Time frame
This study will assess in women with a request for pain relief during labour the cost-effectiveness of RPCA as first choice treatment compared to EA. We will look at the following outcomes: costs, pain relief scores (pain-appreciation	—

Countries

Netherlands

Outcome results